drugset
drugset / Trial / NCT04983849

Evaluation of Metronidazole Hydrogel 25% in Stage II and III Periodontitis

NCT04983849 ↗

Phase 4 Completed 40 enrolled University of L'Aquila
RandomizedCrossoverDouble-blindTreatment

Summary

A randomized clinical trial will be performed single-blind to evaluate the effectiveness of sublingual metronidazole hydrogel 25 % in periodontitis.

Timeline

Start
2021-07-07
Primary completion
2021-07-07
Completion
2021-07-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metronidazole Small molecule 25 % Other

Indications

periodontitis